These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Will 18F-sodium fluoride PET-CT imaging be the magic bullet for identifying vulnerable coronary atherosclerotic plaques? Joshi NV; Vesey A; Newby DE; Dweck MR Curr Cardiol Rep; 2014 Sep; 16(9):521. PubMed ID: 25103772 [TBL] [Abstract][Full Text] [Related]
47. Assessing Coronary Artery and Aortic Calcification in Patients with Prostate Cancer Using Raynor WY; Borja AJ; Zhang V; Kothekar E; Lau HC; Ng SJ; Seraj SM; Rojulpote C; Taghvaei R; Jin KY; Werner TJ; Høilund-Carlsen PF; Alavi A; Revheim ME PET Clin; 2022 Oct; 17(4):653-659. PubMed ID: 36229106 [TBL] [Abstract][Full Text] [Related]
48. Detection and global quantification of cardiovascular molecular calcification by fluoro18-fluoride positron emission tomography/computed tomography--a novel concept. Beheshti M; Saboury B; Mehta NN; Torigian DA; Werner T; Mohler E; Wilensky R; Newberg AB; Basu S; Langsteger W; Alavi A Hell J Nucl Med; 2011; 14(2):114-20. PubMed ID: 21761011 [TBL] [Abstract][Full Text] [Related]
49. A longitudinal pilot study to assess temporal changes in coronary arterial Kitagawa T; Sasaki K; Fujii Y; Tatsugami F; Awai K; Hirokawa Y; Nakano Y J Nucl Cardiol; 2023 Jun; 30(3):1158-1165. PubMed ID: 35488027 [TBL] [Abstract][Full Text] [Related]
50. Correlation of inflammation assessed by 18F-FDG PET, active mineral deposition assessed by 18F-fluoride PET, and vascular calcification in atherosclerotic plaque: a dual-tracer PET/CT study. Derlin T; Tóth Z; Papp L; Wisotzki C; Apostolova I; Habermann CR; Mester J; Klutmann S J Nucl Med; 2011 Jul; 52(7):1020-7. PubMed ID: 21680686 [TBL] [Abstract][Full Text] [Related]
51. Associations between coronary/aortic Wen W; Gao M; Yun M; Meng J; Zhu Z; Yu W; Hacker M; Yu Y; Zhang X; Li X J Nucl Cardiol; 2022 Dec; 29(6):3352-3365. PubMed ID: 35415825 [TBL] [Abstract][Full Text] [Related]
56. Coronary artery 18F-NaF PET analysis with the use of an elastic motion correction software. Bellinge JW; Majeed K; Carr SS; Jones J; Hong I; Francis RJ; Schultz CJ J Nucl Cardiol; 2020 Jun; 27(3):952-961. PubMed ID: 30684262 [TBL] [Abstract][Full Text] [Related]
58. Evaluation of synergistic image registration for motion-corrected coronary NaF-PET-MR. Mayer J; Jin Y; Wurster TH; Makowski MR; Kolbitsch C Philos Trans A Math Phys Eng Sci; 2021 Jun; 379(2200):20200202. PubMed ID: 33966463 [TBL] [Abstract][Full Text] [Related]
59. Evolving Role of Molecular Imaging with (18)F-Sodium Fluoride PET as a Biomarker for Calcium Metabolism. Raynor W; Houshmand S; Gholami S; Emamzadehfard S; Rajapakse CS; Blomberg BA; Werner TJ; Høilund-Carlsen PF; Baker JF; Alavi A Curr Osteoporos Rep; 2016 Aug; 14(4):115-25. PubMed ID: 27301549 [TBL] [Abstract][Full Text] [Related]
60. Clinical implication of 18F-NaF PET/computed tomography indexes of aortic calcification in coronary artery disease patients: correlations with cardiovascular risk factors. Ryoo HG; Paeng JC; Koo BK; Cheon GJ; Lee DS; Kang KW Nucl Med Commun; 2020 Jan; 41(1):58-64. PubMed ID: 31764599 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]